When we work together, we are more than the sum of our parts.
Building a brain implant to predict and prevent epileptic seizures
Carbon Cybernetics has designed an implantable device that can measure activity in individual brain cells.
Detecting epileptic seizures with an implantable device
A device to detect and eventually predict epileptic seizures is undergoing a Phase I clinical trial.
Developing an inhalable drug for hard-to-treat asthma
Pieris Pharmaceuticals’ drug, which was developed in collaboration with University of Melbourne researchers, has successfully completed Phase I clinical trials.
Guiding the design of hospitals as supportive spaces
Architectural practice Lyons worked with University of Melbourne researchers to develop guidelines for designing hospitals that support the health and wellbeing of patients, caregivers and staff.
Improving epilepsy diagnosis with a wearable device
A portable system for diagnosing epilepsy is now available across Australia and will soon be introduced in the UK and Germany.
Stopping the fibrosis causing chronic kidney disease
Certa Therapeutics has developed a drug to prevent fibrosis, a leading cause of end-stage kidney disease. The drug is based on research from the University of Melbourne and affiliated organisations.
Treating common forms of arthritis with a drug to prevent inflammation
GSK is trialing an arthritis drug that prevents the inflammation responsible for bone damage and pain. The drug is based on discoveries made by University of Melbourne researchers.
Treating the pain of knee osteoarthritis
ASICS Oceania worked with University of Melbourne researchers to design a sports shoe that relieves the pain of knee osteoarthritis.